Skip to content

Comparative study to assess the effect of Ayurvedic Drugs in the Management of Headache.

A Comparative Clinical Study of Ayurvedic Interventions in the Management of Ardhavabhedaka With Special Reference to "?? ??????????? ????? ???????? ????? ?? ?????" - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063573
Enrollment
60
Registered
2024-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Institute of Medical Science Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having complaints of - Paroxymal (Pakshat, Maasat, Dashahat, Akasmat), unilateral headache (Ardha shira Vedana) associated with any one symptom among bheda, toda, shoola (Pulsating, throbbing type of pain). Atleast one of the following complaints accompanying the above- Prakasha Asahishnuta (Photophobia), Badhyate swanatah srotre (Phonophobia), Hrullasa , Chardi, bhrama. Patients eligible for nasya karma .

Exclusion criteria

Exclusion criteria: Patients having symptoms of pitta-anubandhi Ardhavabhdeka. Pregnant and lactating women. Patients suffering from major diseases – Tuberculosis, cancer, Diabetes mellitus Heart disease, Hypertension etc. Secondary headache caused by meningitis, tumour, encephalitis, cervical spondylosis and refractive errors.

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptoms of the disease.The main sign and symptoms in the study are as follows: severity of headache Frequency of headache Duration of headache Nausea Vomiting Photobhobia PhonobhobiaTimepoint: 60 days study with follow up at every 20th day.

Secondary

MeasureTime frame
relief in signs & symptoms of patient.Timepoint: After 20th day, 40th day , 60th day there should be reduction in grading of symptoms.

Countries

India

Contacts

Public ContactProf Murlidhar Paliwal

Institute of Medical Science BHU

Naina2121negi@gmail.com6397020424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026